Notification of Shareholding
24 Abril 2008 - 5:58AM
UK Regulatory
RNS Number:0179T
Arana Therapeutics Limited
24 April 2008
For Immediate Release 24 April 2008
Arana Therapeutics Limited
Notification of Shareholding
Arana Therapeutics Limited, (AIM: AAHx ASX: AAH) (the "Company"), the Australian
biopharmaceutical company that uses superior technology to develop next
generation drugs that will improve the lives of patients with inflammatory
diseases and cancer advises that on 22 April 2008 Sun Hung Kai Investment
Services Limited advised the Australian Securities Exchange (www.asx.com.au)
(ASX) that it and its associates (as defined under the Corporations Act 2001
(Australia)) held a total of 11,854,898 ordinary shares in the Company (5.04% of
the issued share capital of the Company) as at 7 April 2008, compared with
10,755,431 ordinary shares of the Company (4.58 % of the issued share capital of
the Company) as at 28 August 2007. A copy of the notice filed by Sun Hung Kai
Investment Services Limited on 22 April 2008 is attached.
For further information, please contact:
Arana Therapeutics Limited
Dr John Chiplin, Chief Executive Officer +61 (0)2 8061 9900
Niall Henderson, Chief Financial Officer +61 (0)2 8061 9900
Buchanan Communication
Lisa Baderoon/Rebecca Skye Dietrich +44 (0)20 7466 5000
Nomura Code Securities
Charles Walker +44 (0)20 7776 1206
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGIGDSUUDGGIS
Arana Therap. (LSE:AAHX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Arana Therap. (LSE:AAHX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Arana Therap. da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de Arana Therapeutics